The announcement coincides with the USCAP 112th Annual Meeting held March 11-16 at the New Orleans Ernest N. Morial Convention Center in New Orleans, Louisiana. "We are delighted to further extend our partnership in this emerging era of personalized medicine." The increasing prevalence of chronic conditions is predicted to intensify the urgency of pathologists seeking to adopt innovative digital pathology solutions to improve existing patient diagnostic imaging methods and reduce the high cost associated with traditional diagnostics. Technological advances in the past decade and the numerous benefits of digital pathology are driving the practice to become widely adopted. Agilent and Visiopharm have collaborated since 2020, developing an integrated solution comprising Visiopharm's portfolio of leading artificial intelligence (AI)-driven precision pathology software and Agilent's automated pathology staining solutions.

The development of digital pathology has resulted in radically better patient care and medical research. The cellular microenvironment is complex, but the introduction of tools like Imaging Mass CytometryTM (IMCTM, Fluidigm) and high-plex fluorescence staining panels has boosted researchers' capacity to probe it (e.g. The development of techniques for spotting significant variations in the datasets has become more difficult as a result of increases in the volume and complexity of the data that these technologies produce. Dr. Heather Stevenson is the Director of Transplantation Pathology at the University of Texas Medical Branch and an Associate Professor there. Her main area of study is hepatic immunology, specifically how dysregulation of the immune system contributes to the fibrosis development.

Imagine an APP for nuclei segmentation that is reliable and can be used by anyone in your lab. Recent advances in deep learning and artificial intelligence have enabled Visiopharm to develop novel tools for nuclei segmentation in brightfield images, providing you with the accuracy, precision and ease-of-use you have been waiting for. Whether you are an image analysis expert or a novice user, you can expect results quickly. This presentation will highlight Visiopharm's new AI Nuclei APP and how it can be combined with other AI and machine learning APPs to generate accurate and meaningful results. Can't make it to this webinar?